Migraine was not associated with BC in a pooled analysis of prospective cohort studies

December 12, 2014

Migraine was not associated with breast cancer risk or differences in the endogenous sex hormones that have been proposed to be associated with migraines, according to a new study published December 12 in the JNCI: Journal of the National Cancer Institute.

Studies linking migraine to breast cancer have reported inconsistent results. Furthermore, a biological mechanism underlying such an association has not been investigated although some have proposed that endogenous hormone levels, including estrogen, may be responsible because higher hormone levels have been associated with breast cancer and fluctuating levels have been shown to trigger migraines. To investigate this further, Rulla M. Tamimi, Sc.D., from the Channing Division of Network Medicine at the Department of Medicine at Brigham and Women's Hospital at Harvard Medical School in Boston, MA, and colleagues, analyzed data from 115,378 women, 17,696 of whom who reported a physician's diagnosis of migraine and found migraine was not associated with breast cancer. Furthermore, among 2034 premenopausal women, endogenous sex hormone levels did not differ by migraine status. The authors next performed a meta-analysis of 5 studies (including their study) and found migraine was associated with a lower risk of breast cancer overall, but when they stratified by study design this relationship was limited to the pooled case-control studies but not the pooled prospective cohort studies. The difference in findings according to study designs, may reflect additional limitations that may occur in case-control studies that can be more easily avoided in prospective cohort studies.

The authors conclude, "In this large cohort study, migraine was not associated with breast cancer risk or differences in endogenous sex hormone levels."
-end-
Contact information:

Rulla M. Tamimi, Sc.D. (e-mail: rulla.tamimi@channing.harvard.edu)

Oxford University Press USA

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.